within Pharmacolibrary.Drugs.ATC.S;

model S02AA01_1
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.8,
    Cl             = 21.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 1000 / 1000000,
    adminCount     = 1,
    Vd             = 0.0005600000000000001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0016666666666666668,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Chloramphenicol is a broad-spectrum antibiotic that inhibits bacterial protein synthesis by binding to the 50S ribosomal subunit. It is used to treat serious infections such as typhoid fever, meningitis, and eye infections, though its use has declined due to potentially severe side effects like aplastic anemia. It is still used in some countries, and topically for eye infections in others.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters in healthy adults after oral administration.</p><h4>References</h4><ol><li><p>KuKanich, B, &amp; KuKanich, K (2015). Chloramphenicol significantly affects the pharmacokinetics of oral methadone in Greyhound dogs. <i>Veterinary anaesthesia and analgesia</i> 42(6) 597–607. DOI:<a href=&quot;https://doi.org/10.1111/vaa.12257&quot;>10.1111/vaa.12257</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/25733012/&quot;>https://pubmed.ncbi.nlm.nih.gov/25733012</a></p></li><li><p>McElligott, EM, et al., &amp; Cox, SK (2017). Pharmacokinetics of chloramphenicol base after oral administration in adult horses. <i>Journal of the American Veterinary Medical Association</i> 251(1) 90–94. DOI:<a href=&quot;https://doi.org/10.2460/javma.251.1.90&quot;>10.2460/javma.251.1.90</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/28621597/&quot;>https://pubmed.ncbi.nlm.nih.gov/28621597</a></p></li><li><p>Crump, JA, et al., &amp; Parry, CM (2015). Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections. <i>Clinical microbiology reviews</i> 28(4) 901–937. DOI:<a href=&quot;https://doi.org/10.1128/CMR.00002-15&quot;>10.1128/CMR.00002-15</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26180063/&quot;>https://pubmed.ncbi.nlm.nih.gov/26180063</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end S02AA01_1;
